Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aspire Biopharma Holdings, Inc. - Common Stock (NQ:ASBP)

5.040 -0.370 (-6.84%)
Streaming Delayed Price Updated: 2:53 PM EDT, May 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 62,665
Open 5.430
Bid (Size) 5.040 (200)
Ask (Size) 5.110 (200)
Prev. Close 5.410
Today's Range 4.860 - 5.440
52wk Range 0.1103 - 35.01
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Get insights into the top gainers and losers of Friday's after-hours session. ↗
Via Chartmill
Gapping stocks in Friday's session ↗
Via Chartmill

Performance

YTD
-8.0%
-8.0%
1 Month
+1957.1%
+1957.1%
3 Month
+287.7%
+287.7%
6 Month
+26.0%
+26.0%
1 Year
-46.9%
-46.9%

More News

Read More
Which stocks are moving before the opening bell on Friday? ↗
Via Chartmill
These stocks are the most active in today's session ↗
Via Chartmill
News headline image
Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio
Via ACCESS Newswire
Which stocks are moving before the opening bell on Thursday? ↗
Via Chartmill
What's going on in today's after hours session ↗
Via Chartmill
Monday's session: most active stocks ↗
Via Chartmill
News headline image
Aspire Biopharma Announces $5.0 Million Share Repurchase Program
Via ACCESS Newswire
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
Top movers in Tuesday's session ↗
Via Chartmill
Unusual volume stocks are being observed in Tuesday's session. ↗
Via Chartmill
These stocks are moving in today's session ↗
Via Chartmill
News headline image
Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition
Via ACCESS Newswire
News headline image
Aspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo
Via ACCESS Newswire
News headline image
Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue
Via ACCESS Newswire
News headline image
These stocks are moving in today's session ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
Here are the top movers in Wednesday's session. ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
Wednesday's session: gap up and gap down stocks ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
These stocks are moving in today's pre-market session ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
Aspire Biopharma's Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail Expansion
Via ACCESS Newswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Wednesday's session: top gainers and losers ↗
Via Chartmill
News headline image
Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion
Via ACCESS Newswire
News headline image
Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director
Via ACCESS Newswire

Frequently Asked Questions

Is Aspire Biopharma Holdings, Inc. - Common Stock publicly traded?
Yes, Aspire Biopharma Holdings, Inc. - Common Stock is publicly traded.
What exchange does Aspire Biopharma Holdings, Inc. - Common Stock trade on?
Aspire Biopharma Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aspire Biopharma Holdings, Inc. - Common Stock?
The ticker symbol for Aspire Biopharma Holdings, Inc. - Common Stock is ASBP on the Nasdaq Stock Market
What is the current price of Aspire Biopharma Holdings, Inc. - Common Stock?
The current price of Aspire Biopharma Holdings, Inc. - Common Stock is 5.040
When was Aspire Biopharma Holdings, Inc. - Common Stock last traded?
The last trade of Aspire Biopharma Holdings, Inc. - Common Stock was at 05/26/26 02:53 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.